|
Editorial |
| Applications of human brain organoids |
| Alysson Renato Muotri |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e13 |
|
|
|
|
Original Articles |
| A method for culturing patient-derived lung cancer organoids from surgically resected tissues and biopsy samples |
| Yu Ri Ko, Ji Min Kim, Younsoo Kang, Minsuh Kim, Se Jin Jang |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e19 |
|
|
|
| Standard operating protocol of hepatic organoid differentiation from human induced pluripotent stem cells |
| Min Jung Kim, Jaeseo Lee, Seon Ju Mun, Myung Jin Son, Jung-Hyun Kim |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e5 |
|
|
|
| Three-dimensional cardiac organoid formation accelerates the functional maturation of human induced pluripotent stem cell-derived cardiomyocytes |
| Hanbyeol Lee, Jeong Suk Im, Da Bin Choi, Jieun An, Su-Bin Kim, Seunghee Yeon, Seulgi Yoon, Dong-Hun Woo |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e14 |
|
|
|
|
Review Articles |
| Technical advances in pluripotent stem cell-derived and tumorigenic organoids |
| Suwon Kang, Eun Kyung Bong, Hyo-Min Kim, Tae-Young Roh |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e18 |
|
|
|
| Disease modeling in organoid cultures: a new tool for studying viruses |
| Jaewon Cho, Eun-Hye Hong, Hyun-Jeong Ko |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e15 |
|
|
|
| Advanced human liver models for the assessment of drug-induced liver injury |
| Seon Ju Mun, Jaeseo Lee, Yongbo Shin, Myung Jin Son |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e17 |
|
|
|
| Understanding the cellular pathogenesis of COVID-19 symptoms using organoid technology |
| Young Hyun Che, Yong Jun Kim |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e16 |
|
|
|
| Recent advances and challenges in organoid-on-a-chip technology |
| Intan Rosalina Suhito, Tae-Hyung Kim |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e4 |
|
|
|
| Progress, prospects, and limitations of organoid technology |
| Jin Hee Park, Do Gyeung Byeun, Jung Kyu Choi |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e9 |
|
|
|
| Emerging organoid-based platforms to study salivary gland hypofunction |
| Yoojin Seo, Hyung-Sik Kim |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e2 |
|
|
|
| Fundamental signaling pathways for glioblastoma drug resistance and developing robust organoid models for drug discovery |
| Athira Pratap, Eun-Jung Lim, Ihn-Sil Kwak, Byoung-San Moon |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e8 |
|
|
|
| Biomimetic in vitro heart platforms for drug development |
| Sungwoo Cho, Sungho Ko |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e1 |
|
|
|
| Glioblastoma organoid technology: an emerging preclinical models for drug discovery |
| Don Carlo Ramos Batara, Shuchang Zhou, Moon-Chang Choi, Sung-Hak Kim |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e7 |
|
|
|
| The application of intestinal organoids and their co-culture systems in the study of gastrointestinal diseases |
| Panida Sittipo, Yun Kyung Lee |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e3 |
|
|
|
| Recent advances in liver organoids and their use in in vitro modeling of non-alcoholic fatty liver disease |
| Kyun Yoo Chi, Jong-Hoon Kim |
|
DOI: https://doi.org/10.51335/organoid.2022.2.e6 |
|
|
|
Notice
Full text
PubReader
ePub
PDF
Supplementary Material